(Q34498982)

2 August 2017

Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases (English)

1 reference

2 August 2017

1 reference

Jo-Anne H van Burik

1

1 reference

2 August 2017

Roberta S Hare

2

1 reference

2 August 2017

Howard F Solomon

3

1 reference

2 August 2017

Michael L Corrado

4

1 reference

2 August 2017

Dimitrios P Kontoyiannis

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

21 February 2006

1 reference

Clinical Infectious Diseases

2 August 2017

1 reference

2 August 2017

42

1 reference

2 August 2017

7

1 reference

2 August 2017

e61-5

1 reference

Zygomycetes in human disease

2 August 2017

1 reference

Epidemiology and outcome of zygomycosis: a review of 929 reported cases

21 January 2018

1 reference

Zygomycosis (mucormycosis): emerging clinical importance and new treatments

21 January 2018

1 reference

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases

21 January 2018

1 reference

Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections.

21 January 2018

1 reference

In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes

21 January 2018

1 reference

In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model

21 January 2018

1 reference

Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazole therapy

21 January 2018

1 reference

Posaconazole as salvage therapy for zygomycosis

21 January 2018

1 reference

Activity of posaconazole in the treatment of central nervous system fungal infections

21 January 2018

1 reference

Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults

21 January 2018

1 reference

Oral bioavailability of posaconazole in fasted healthy subjects: comparison between three regimens and basis for clinical dosage recommendations

21 January 2018

1 reference

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer

21 January 2018

1 reference

Toward more effective antifungal therapy: the prospects of combination therapy.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/500212

1 reference

2 August 2017

1 reference